Licensing Opportunities
Late-stage and commercial pharmaceutical licensing opportunities across the UK, Ireland, the Nordics, and wider European markets.
Learn MoreWe partner with organisations to maximise the value of late-stage and ready-to-market pharmaceutical products and assets through licensing and acquisition opportunities.
We focus on partnering with organisations that have late-stage, approved or ready-to-market pharmaceutical products and assets with strong commercial potential.
Our experienced teams work closely with partners throughout the evaluation, due diligence and commercialisation process, providing the regulatory, quality, supply chain and commercial expertise needed to maximise product value and support long-term success.
We focus on partnership opportunities involving pharmaceutical products and assets that align with our expertise and strategic objectives.
Late-stage and commercial pharmaceutical licensing opportunities across the UK, Ireland, the Nordics, and wider European markets.
Learn MoreWe evaluate acquisition opportunities involving companies, marketed products, product portfolios and pharmaceutical assets that strengthen our business and support long-term growth.
Learn MoreOur partnership approach combines pharmaceutical expertise, operational excellence and a commitment to delivering mutually beneficial outcomes.
Established experience launching and growing pharmaceutical products across the UK, Ireland and European markets.
Dedicated regulatory, pharmacovigilance and quality teams supporting compliant product commercialisation.
Strong relationships and infrastructure across key healthcare markets.
Focused on sustainable growth and shared commercial success.
Through Galen and POA Pharma, we provide integrated licensing and commercial capabilities across the UK, Ireland, the Nordics, and wider European markets.
Operating as part of Galen Limited, POA Pharma extends our regional infrastructure and market expertise across key European territories, enabling a coordinated approach to licensing, commercialisation, and lifecycle management.
Founded in 1968 in Northern Ireland, Galen is a privately owned pharmaceutical company with established commercial operations across the UK and Ireland.
We support pharmaceutical products throughout the full commercial lifecycle, from licensing and market entry through to long-term commercial growth and supply management.
Headquartered in Copenhagen, POA Pharma expands our integrated licensing and commercial capabilities across key Nordic and European markets.
Through established regional expertise and commercial infrastructure, POA Pharma supports market access, distribution, and product commercialisation across multiple European territories.
Whether you have a late-stage or ready-to-market pharmaceutical product or asset, or are exploring a strategic acquisition opportunity, our Business Development team would welcome the opportunity to connect.